Targeted polymeric therapeutic nanoparticles: design, development and clinical translation
Top Cited Papers
- 5 March 2012
- journal article
- review article
- Published by Royal Society of Chemistry (RSC) in Chemical Society Reviews
- Vol. 41 (7), 2971-3010
- https://doi.org/10.1039/c2cs15344k
Abstract
Polymeric materials have been used in a range of pharmaceutical and biotechnology products for more than 40 years. These materials have evolved from their earlier use as biodegradable products such as resorbable sutures, orthopaedic implants, macroscale and microscale drug delivery systems such as microparticles and wafers used as controlled drug release depots, to multifunctional nanoparticles (NPs) capable of targeting, and controlled release of therapeutic and diagnostic agents. These newer generations of targeted and controlled release polymeric NPs are now engineered to navigate the complex in vivo environment, and incorporate functionalities for achieving target specificity, control of drug concentration and exposure kinetics at the tissue, cell, and subcellular levels. Indeed this optimization of drug pharmacology as aided by careful design of multifunctional NPs can lead to improved drug safety and efficacy, and may be complimentary to drug enhancements that are traditionally achieved by medicinal chemistry. In this regard, polymeric NPs have the potential to result in a highly differentiated new class of therapeutics, distinct from the original active drugs used in their composition, and distinct from first generation NPs that largely facilitated drug formulation. A greater flexibility in the design of drug molecules themselves may also be facilitated following their incorporation into NPs, as drug properties (solubility, metabolism, plasma binding, biodistribution, target tissue accumulation) will no longer be constrained to the same extent by drug chemical composition, but also become in-part the function of the physicochemical properties of the NP. The combination of optimally designed drugs with optimally engineered polymeric NPs opens up the possibility of improved clinical outcomes that may not be achievable with the administration of drugs in their conventional form. In this critical review, we aim to provide insights into the design and development of targeted polymeric NPs and to highlight the challenges associated with the engineering of this novel class of therapeutics, including considerations of NP design optimization, development and biophysicochemical properties. Additionally, we highlight some recent examples from the literature, which demonstrate current trends and novel concepts in both the design and utility of targeted polymeric NPs (444 references).Keywords
This publication has 415 references indexed in Scilit:
- More Effective Nanomedicines through Particle DesignSmall, 2011
- Differentially Charged Hollow Core/Shell Lipid–Polymer–Lipid Hybrid Nanoparticles for Small Interfering RNA DeliveryAngewandte Chemie International Edition, 2011
- Synthesis of Size‐Tunable Polymeric Nanoparticles Enabled by 3D Hydrodynamic Flow Focusing in Single‐Layer MicrochannelsAdvanced Materials, 2011
- Surface Modification of Polymeric Micelles by Strain-Promoted Alkyne-Azide CycloadditionsChemistry – A European Journal, 2010
- Fast and Sensitive Pretargeted Labeling of Cancer Cells through a Tetrazine/trans‐Cyclooctene CycloadditionAngewandte Chemie International Edition, 2009
- Molecular Assembly of an Aptamer–Drug Conjugate for Targeted Drug Delivery to Tumor CellsChemBioChem, 2009
- HER‐2‐Targeted Nanoparticle–Affibody Bioconjugates for Cancer TherapyChemMedChem, 2008
- Doxorubicin‐Loaded Polymeric Micelle Overcomes Multidrug Resistance of Cancer by Double‐Targeting Folate Receptor and Early Endosomal pHSmall, 2008
- Sheddable Coatings for Long-Circulating NanoparticlesPharmaceutical Research, 2007
- Lysosomal Sequestration of Amine-Containing Drugs: Analysis and Therapeutic ImplicationsJournal of Pharmaceutical Sciences, 2007